Skip to main content

Oligonucleotide API Manufacturing

Manufacturing Late Stage and Commercial Quantities

Agilent is dedicated to current good manufacturing practices (cGMP) as defined by ICH for providing active pharmaceutical ingredients (APIs). We own two facilities equipped to serve all your oligo API needs. The 77,000 square foot cGMP facility located in Boulder, Colorado, USA, houses multiple suites enabling the manufacture of several products simultaneously. A broad range of synthesis and purification equipment allows for production for toxicology and preclinical use to late-stage clinical trials and commercial launch. Our latest 135,000 square foot cGMP facility located in Frederick, Colorado, has enabled us to more than double our clinical/commercial manufacturing capacity for nucleic acid-based therapeutics.
Contact Us
+1 866-744-7638

Refine By



Sort Alphabetically

Filter by
Filter Content Selection Tool

Need Help? Find products using our Selection Tool.

0 product selected.

Clear All